Accéder au contenu
Merck

Interaction of aliphatic cap group in inhibition of histone deacetylases by cyclic tetrapeptides.

Bioorganic & medicinal chemistry (2007-09-29)
Norikazu Nishino, Gururaj M Shivashimpi, Preeti B Soni, Mohammed P I Bhuiyan, Tamaki Kato, Satoko Maeda, Tomonori G Nishino, Minoru Yoshida
RÉSUMÉ

Inhibitors of histone deacetylases (HDACs) are a promising class of anticancer agents that effect gene regulation. To know the interaction of aliphatic cap groups with HDACs, cyclic tetrapeptide and bicyclic peptide disulfide hybrids were synthesized without aromatic ring in their macrocyclic framework. Benzene ring of l-Phe in chlamydocin was replaced with several aliphatic amino acids and also a fused bicyclic tetrapeptide was synthesized by ring closing metathesis using Grubb's first generation catalyst. The inhibitory activities of the cyclic peptides against histone deacetylase enzymes were evaluated, which demonstrated most of them are interesting candidates as anticancer agents.